Sven Pålhagen

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. ncbi Selegiline slows the progression of the symptoms of Parkinson disease
    S Palhagen
    Department of Neurology, Karolinska University Hospital Huddinge, SE 141 86 Stockholm, Sweden
    Neurology 66:1200-6. 2006
  2. ncbi Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    S E Palhagen
    Department of Clinical Neuroscience, Division of Neurology Huddinge, Karolinska Institute, Stockholm, Sweden
    Acta Neurol Scand 117:295-304. 2008
  3. ncbi HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment
    Sven E Pålhagen
    Department of Clinical Neuroscience, Division of Neurology Huddinge, Karolinska Institute, Stockholm, Sweden
    J Neurol 256:1510-8. 2009
  4. ncbi Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression
    Sven Pålhagen
    Section of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
    J Neurol 257:524-32. 2010

Detail Information

Publications4

  1. ncbi Selegiline slows the progression of the symptoms of Parkinson disease
    S Palhagen
    Department of Neurology, Karolinska University Hospital Huddinge, SE 141 86 Stockholm, Sweden
    Neurology 66:1200-6. 2006
    ..To study the long-term effects of selegiline in monotherapy and in combination with levodopa in the early phase of Parkinson disease (PD)...
  2. ncbi Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    S E Palhagen
    Department of Clinical Neuroscience, Division of Neurology Huddinge, Karolinska Institute, Stockholm, Sweden
    Acta Neurol Scand 117:295-304. 2008
    ....
  3. ncbi HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment
    Sven E Pålhagen
    Department of Clinical Neuroscience, Division of Neurology Huddinge, Karolinska Institute, Stockholm, Sweden
    J Neurol 256:1510-8. 2009
    ..These observations support our hypothesis that PD combined with MD is an expression of a more advanced and widespread neurodegenerative disorder...
  4. ncbi Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression
    Sven Pålhagen
    Section of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
    J Neurol 257:524-32. 2010
    ..Thus, the biochemical basis and the response to citalopram differ between PD patients with MD and patients with solely MD...